📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trial. (2021)

First Author: Cordoba S

Attributed to: Second Generation Bio-Lentivir Packaging Cell Line for Facile Lentivirus Production funded by EPSRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s41591-021-01497-1

PubMed Identifier: 34642489

Publication URI: http://europepmc.org/abstract/MED/34642489

Type: Journal Article/Review

Volume: 27

Parent Publication: Nature medicine

Issue: 10

ISSN: 1078-8956